BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23404206)

  • 1. Three-fraction CyberKnife radiotherapy for brain metastases in critical areas: referring to the risk evaluating radiation necrosis and the surrounding brain volumes circumscribed with a single dose equivalence of 14 Gy (V14).
    Inoue HK; Seto K; Nozaki A; Torikai K; Suzuki Y; Saitoh J; Noda SE; Nakano T
    J Radiat Res; 2013 Jul; 54(4):727-35. PubMed ID: 23404206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Five-fraction CyberKnife radiotherapy for large brain metastases in critical areas: impact on the surrounding brain volumes circumscribed with a single dose equivalent of 14 Gy (V14) to avoid radiation necrosis.
    Inoue HK; Sato H; Seto K; Torikai K; Suzuki Y; Saitoh J; Noda SE; Nakano T
    J Radiat Res; 2014 Mar; 55(2):334-42. PubMed ID: 24187332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal hypofractionated conformal radiotherapy for large brain metastases in patients with high risk factors: a single-institutional prospective study.
    Inoue HK; Sato H; Suzuki Y; Saitoh J; Noda SE; Seto K; Torikai K; Sakurai H; Nakano T
    Radiat Oncol; 2014 Oct; 9():231. PubMed ID: 25322826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cyberknife radiosurgery/radiotherapy for brain metastases of multiple or large-size tumors.
    Nishizaki T; Saito K; Jimi Y; Harada N; Kajiwara K; Nomura S; Ishihara H; Yoshikawa K; Yoneda H; Suzuki M; Gibbs IC
    Minim Invasive Neurosurg; 2006 Aug; 49(4):203-9. PubMed ID: 17041830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new strategy of CyberKnife treatment system based radiosurgery followed by early use of adjuvant bevacizumab treatment for brain metastasis with extensive cerebral edema.
    Wang Y; Wang E; Pan L; Dai J; Zhang N; Wang X; Liu X; Mei G; Sheng X
    J Neurooncol; 2014 Sep; 119(2):369-76. PubMed ID: 24879376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-fraction radiosurgery versus fractionated stereotactic radiotherapy in patients with brain metastases: a comparative study.
    Loo M; Pin Y; Thierry A; Clavier JB
    Clin Exp Metastasis; 2020 Jun; 37(3):425-434. PubMed ID: 32185576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic radiosurgery for brain metastases: analysis of outcome and risk of brain radionecrosis.
    Minniti G; Clarke E; Lanzetta G; Osti MF; Trasimeni G; Bozzao A; Romano A; Enrici RM
    Radiat Oncol; 2011 May; 6():48. PubMed ID: 21575163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extent of perilesional edema differentiates radionecrosis from tumor recurrence following stereotactic radiosurgery for brain metastases.
    Leeman JE; Clump DA; Flickinger JC; Mintz AH; Burton SA; Heron DE
    Neuro Oncol; 2013 Dec; 15(12):1732-8. PubMed ID: 24243914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypofractionated stereotactic radiotherapy for brain metastases larger than three centimeters.
    Jiang XS; Xiao JP; Zhang Y; Xu YJ; Li XP; Chen XJ; Huang XD; Yi JL; Gao L; Li YX
    Radiat Oncol; 2012 Mar; 7():36. PubMed ID: 22429918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeat stereotactic radiosurgery as salvage therapy for locally recurrent brain metastases previously treated with radiosurgery.
    McKay WH; McTyre ER; Okoukoni C; Alphonse-Sullivan NK; Ruiz J; Munley MT; Qasem S; Lo HW; Xing F; Laxton AW; Tatter SB; Watabe K; Chan MD
    J Neurosurg; 2017 Jul; 127(1):148-156. PubMed ID: 27494815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival following CyberKnife radiosurgery and hypofractionated radiotherapy for newly diagnosed glioblastoma multiforme.
    Lipani JD; Jackson PS; Soltys SG; Sato K; Adler JR
    Technol Cancer Res Treat; 2008 Jun; 7(3):249-55. PubMed ID: 18473497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metastases treated with hypofractionated stereotactic radiotherapy: 8 years experience after Cyberknife installation.
    Mengue L; Bertaut A; Ngo Mbus L; Doré M; Ayadi M; Clément-Colmou K; Claude L; Carrie C; Laude C; Tanguy R; Blanc J; Sunyach MP
    Radiat Oncol; 2020 Apr; 15(1):82. PubMed ID: 32303236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five-fraction stereotactic radiosurgery (SRS) for single inoperable high-risk non-small cell lung cancer (NSCLC) brain metastases.
    Lischalk JW; Oermann E; Collins SP; Nair MN; Nayar VV; Bhasin R; Voyadzis JM; Rudra S; Unger K; Collins BT
    Radiat Oncol; 2015 Oct; 10():216. PubMed ID: 26503609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the radiosurgery prescription dose on the local control of small (2 cm or smaller) brain metastases.
    Mohammadi AM; Schroeder JL; Angelov L; Chao ST; Murphy ES; Yu JS; Neyman G; Jia X; Suh JH; Barnett GH; Vogelbaum MA
    J Neurosurg; 2017 Mar; 126(3):735-743. PubMed ID: 27231978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiation-induced changes of brain tissue after radiosurgery in patients with arteriovenous malformations: correlation with dose distribution parameters.
    Levegrün S; Hof H; Essig M; Schlegel W; Debus J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):796-808. PubMed ID: 15183483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CyberKnife Frameless Radiosurgery for the treatment of extracranial benign tumors.
    Bhatnagar AK; Gerszten PC; Ozhasaglu C; Vogel WJ; Kalnicki S; Welch WC; Burton SA
    Technol Cancer Res Treat; 2005 Oct; 4(5):571-6. PubMed ID: 16173828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse radiation effect after stereotactic radiosurgery for brain metastases: incidence, time course, and risk factors.
    Sneed PK; Mendez J; Vemer-van den Hoek JG; Seymour ZA; Ma L; Molinaro AM; Fogh SE; Nakamura JL; McDermott MW
    J Neurosurg; 2015 Aug; 123(2):373-86. PubMed ID: 25978710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current dosing paradigm for stereotactic radiosurgery alone after surgical resection of brain metastases needs to be optimized for improved local control.
    Prabhu R; Shu HK; Hadjipanayis C; Dhabaan A; Hall W; Raore B; Olson J; Curran W; Oyesiku N; Crocker I
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e61-6. PubMed ID: 22516387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiosurgery in patients with multiple brain metastases.
    Chang SD; Lee E; Sakamoto GT; Brown NP; Adler JR
    Neurosurg Focus; 2000 Aug; 9(2):e3. PubMed ID: 16836289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.